Author:
Garces Álvaro Henrique Ingles,Dias Mariane Sousa Fontes,Paulino Eduardo,Ferreira Carlos Gil Moreira,de Melo Andréia Cristina
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference82 articles.
1. Romero I, Bast RC Jr (2012) Minireview: human ovarian cancer—biology, current management, and paths to personalizing therapy. Endocrinology 153(4):1593–1602
2. Gui T, Shen K (2012) The epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancer. Cancer Epidemiol 36(5):490–496
3. Mhawech-Fauceglia P, Afkhami M, Pejovic T (2012) MET/HGF signaling pathway in ovarian carcinoma: clinical implications and future direction. Patholog Res Int 2012:960327
4. Modugno F, Laskey R, Smith AL, Andersen CL, Haluska P, Oesterreich S (2012) Hormone response in ovarian cancer: time to reconsider as a clinical target? Endocr Relat Cancer 19(6):R255–R279
5. Jelovac D, Armstrong DK (2012) Role of farletuzumab in epithelial ovarian carcinoma. Curr Pharm Des 18(25):3812–3815
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献